Safety and efficacy of interferon retreatment in children with chronic hepatitis B

European Journal of Pediatrics

Volumn 157, Issue 5, 1998, Pages 382-385

  Ballauff, A ^a   Schneider, T ^c   Gerner, P ^c   Habermehl, P ^c   Behrens, R ^b   Wirth, S ^d  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d HELIOS KLINIKUM WUPPERTAL   (Germany)

Author keywords

Alpha interferon; Children; Chronic hepatitis B; Non responder; Retreatment

Indexed keywords

ALPHA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; INTERFERON; RECOMBINANT ALPHA INTERFERON; VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS B; HUMAN; IMMUNOTHERAPY; LEUKOPENIA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETREATMENT; SCHOOL CHILD; THROMBOCYTOPENIA; TREATMENT FAILURE;

ADOLESCENT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; RECOMBINANT PROTEINS;

EID: 0031968370     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050834     Document Type: Article

References (12)

1. Barbara C, Bortolotti F, Crivellaro C, Coscia A, Zancan L, Cadrobbi P, Nebbia G (1994) Recombinant interferon-alpha 2a hastens the rate of HBeAg clearence in children with chronic hepatitis B. Hepatology 20:287-290
2. Bortolotti F, Cadrobbi P, Crivellaro C, Guido M, Rugge M. Noventa F, Calzia R (1990) Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 99:805-810
3. Conjeevaram HS, Di Bisceglie AM (1995) Management of chronic viral hepatitis in children. J Pediatr Gastroenterol Nutr 20:365-375
4. De Man RA, Heijtink RA, Niesters HGM, Schalm SW (1995) New developments in antiviral therapy for chronic hepatitis B infection. Scand J Gastroenterol 30 [Suppl 212]:100-104
5. Hope RL, Weltman M, Dingley J, Fiatarone J, Hope AH, Craig PI, Grierson JM (1995) Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response. Med J Aust 162:8-11
6. Janssen HLA, Schalm SW, Berk L, de Man RA, Heijtink RA (1993) Repeated courses of α-interferon for treatment of chronic hepatitis type B. J Hepatol 17[Suppl 3]:S47-S51
7. Jonas MM (1996) Interferon-α for viral hepatitis. J Pediatr Gastroenterol Nutr 23:93-106
8. Lok AS, Chung H-T, Liu VWS, Ma OCK (1993) Long-term follow up of chronic hepatitis B patients treated with interferon alpha. Gastroenterology 105:1833-1838
9. Ruiz-Moreno M, Fernandez P, Leal A, Bartolome J, Castillo I, Oliva H, Carreno V (1997) Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon therapy. Pediatrics 99:222-225
10. Sokal EM, Wirth S, Goyens P, Depreterre A, Cornu C (1993) Interferon alfa-2b therapy in children with chronic hepatitis B Gut [Suppl]:S87-S90
11. Teuber G, Dienes H-P, Meyer zum Büschenfelde K-H, Gerken G (1995) Interferon-α-Retherapie der chronischen Hepatitis-B und -C-Virusinfektion. Z Gastroenterol 33:94-98
12. Wirth S, Schneider A, Bahn A, Pohlenz J, Lausch E, Gerken G (1994) Interferon therapy in children with chronic hepatitis B (Abstract). Hepatology 20:87A